Key Financial Data Of Reporting Company

Daito Pharmaceutical Co., Ltd. - Filing #7712791

Concept As at
2019-02-28
2018-06-01 to
2019-02-28
2018-12-01 to
2019-02-28
As at
2018-05-31
2017-06-01 to
2018-05-31
As at
2018-02-28
2017-06-01 to
2018-02-28
2017-12-01 to
2018-02-28
Key financial data of reporting company
Business results of reporting company
Net sales
30,401,398,000 JPY
39,875,983,000 JPY
29,636,902,000 JPY
Ordinary profit (loss)
3,753,009,000 JPY
4,244,028,000 JPY
3,245,387,000 JPY
Net assets
30,484,029,000 JPY
28,495,554,000 JPY
27,930,808,000 JPY
Total assets
49,193,901,000 JPY
46,898,563,000 JPY
46,825,453,000 JPY
Basic earnings (loss) per share
203.81
70.07
243.08
183.81
56.99
Diluted earnings per share
Equity-to-asset ratio
0.611 xbrli:pure
0.598 xbrli:pure
0.587 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.